Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV004799355 | SCV001431206 | uncertain significance | Snijders Blok-Campeau syndrome | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978216 | SCV005557095 | uncertain significance | Inborn genetic diseases | 2024-10-25 | criteria provided, single submitter | clinical testing | The c.5038G>A (p.V1680M) alteration is located in exon 32 (coding exon 32) of the CHD3 gene. This alteration results from a G to A substitution at nucleotide position 5038, causing the valine (V) at amino acid position 1680 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |